s6y
Company name or ticker
Search
ARS Pharmaceuticals, Inc.
S-3
Registration statement for specified transactions by certain issuers
Filed
Monday, January 3, 2022
Accession number
0001193125-22-000630
Documents
S-3
S-3
EX-4.3
EX-4.3
EX-4.6
EX-4.6
EX-4.7
EX-4.7
EX-4.8
EX-4.8
EX-5.1
EX-5.1
EX-23.1
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header